Detailansicht

Wissensnetz

Person

Fred Saad

Urologe

Name	Fred Saad
Ort	Kanada
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Urologe (charakteristischer Beruf) Onkologe
Variante	F. Saad
Beziehung	Université de Montréal (Department of surgery)
Weitere Angaben	Forschungsschwerpunkt: Prostatakrebs, urologische Onkologie
Quelle	LCAuth Internet: http://www.chumtl.qc.ca/crchum/chercheurs/chercheurs-liste/saad-f.en.html (Stand: 29.04.13)
Datensatztyp	Person
GND-Nummer	1034039512
Datensatz-ID	1034039512
Beteiligt an alle anzeigen Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality Radiotherapy Versus Partial Penectomy for T1 Squamous Cell Carcinoma of the Penis Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement The effect of race/ethnicity on cancer-specific mortality after trimodal therapy Adverse in-hospital outcomes after radical prostatectomy in leukemia history patients Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities Epidemiology of Unconventional Histological Subtypes of Urethral Cancer Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Prognostic significance of pathologic lymph node invasion in metastatic renal cell carcinoma in the immunotherapy era Regional differences in clear cell metastatic renal cell carcinoma patients across the USA Survival of testicular pure embryonal carcinoma vs. mixed germ cell tumor patients across all atages Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity Radiation therapy after radical prostatectomy is associated with higher other-cause mortality Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study) Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy Validation of the new STAR-CAP prognostic group staging system in prostate cancer patients treated with radiation therapy Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE) Incidence rates and contemporary trends in primary urethral cancer The impact of sex and age on distribution of metastases in patients with renal cell carcinoma Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients Comparison between urothelial and non-urothelial urethral cancer Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients External beam radiotherapy and radical prostatectomy are associated with better survival in asian prostate cancer patients External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Fred Saad

Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls

Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality

Radiotherapy Versus Partial Penectomy for T1 Squamous Cell Carcinoma of the Penis

Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients

Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma

Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer

Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy

Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement

The effect of race/ethnicity on cancer-specific mortality after trimodal therapy

Adverse in-hospital outcomes after radical prostatectomy in leukemia history patients

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era

ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer

Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls

Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities

Epidemiology of Unconventional Histological Subtypes of Urethral Cancer

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Prognostic significance of pathologic lymph node invasion in metastatic renal cell carcinoma in the immunotherapy era

Regional differences in clear cell metastatic renal cell carcinoma patients across the USA

Survival of testicular pure embryonal carcinoma vs. mixed germ cell tumor patients across all atages

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer

Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis

Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients

Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables

Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients

Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups

Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy

Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients

Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients

Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer

Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients

Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma

The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy

Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy

Validation of the new STAR-CAP prognostic group staging system in prostate cancer patients treated with radiation therapy

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities

Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)

Incidence rates and contemporary trends in primary urethral cancer

The impact of sex and age on distribution of metastases in patients with renal cell carcinoma

Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients

Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients

Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients

Comparison between urothelial and non-urothelial urethral cancer

Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients

External beam radiotherapy and radical prostatectomy are associated with better survival in asian prostate cancer patients

External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients

Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients